Literature DB >> 17318644

Persistence of PAR-2 vasodilation despite endothelial dysfunction in BPH/2 hypertensive mice.

John J McGuire1, Bruce N Van Vliet, José Giménez, James C King, Sarah J Halfyard.   

Abstract

This study investigated relaxation of vascular smooth muscle by acetylcholine, bradykinin and protease-activated receptor 2 (PAR-2) to characterise endothelial dysfunction in spontaneously hypertensive mice (BPH/2). We hypothesised that PAR-2 induced vasodilation would be preserved in BPH/2 despite the presence of hypertension and impaired vasodilator responses to acetylcholine and bradykinin. Mean arterial blood pressure (MAP), heart rate and locomotor activity were assessed in conscious mice over 24-h periods by radiotelemetry. Relaxation responses of small mesenteric arteries to acetylcholine, bradykinin and the PAR-2 agonist, 2-furoyl-LIGRLO-amide (2fly), were assessed using wire myographs. MAP and heart rate of BPH/2 were 15 and 18%, respectively, higher than in controls (BPN/3). BPH/2 also exhibited increased locomotor activity. Maximal relaxations of arteries by acetylcholine and bradykinin in BPH/2 were reduced by 25-50% relative to BPN/3. In contrast, relaxation responses to 2fly were only slightly (6%), albeit significantly, reduced. Sodium nitroprusside-induced relaxations were not different between strains. Treatment of BPH/2 arteries with inhibitors of calcium-activated K(+) channels was sufficient to block persistent 2fly- and residual ACh- and bradykinin-induced relaxations, whereas NO synthase inhibitor failed to inhibit these relaxations. In BPH/2 mice, vascular smooth muscle relaxation by PAR-2 is well preserved despite the presence of hypertension and impaired vasodilation responses to acetylcholine and bradykinin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318644     DOI: 10.1007/s00424-007-0226-2

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  28 in total

1.  Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

Authors:  M J Mulvany; W Halpern
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

2.  Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice.

Authors:  Malarvannan Pannirselvam; Hong Ding; Todd J Anderson; Chris R Triggle
Journal:  Eur J Pharmacol       Date:  2006-09-12       Impact factor: 4.432

3.  Evidence for selective effects of chronic hypertension on cerebral artery vasodilatation to protease-activated receptor-2 activation.

Authors:  C G Sobey; J D Moffatt; T M Cocks
Journal:  Stroke       Date:  1999-09       Impact factor: 7.914

4.  Endothelial dysfunction in the streptozotocin-induced diabetic apoE-deficient mouse.

Authors:  Hong Ding; Michael Hashem; William B Wiehler; Winnie Lau; Jacqueline Martin; Julianne Reid; Chris Triggle
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

5.  Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production.

Authors:  J Bauersachs; A Bouloumié; A Mülsch; G Wiemer; I Fleming; R Busse
Journal:  Cardiovasc Res       Date:  1998-03       Impact factor: 10.787

6.  Proteinase-activated receptor (PAR)-mediated vasorelaxation in pulmonary arteries from normotensive and hypoxic pulmonary hypertensive rats.

Authors:  Janet C Wanstall; A Gambino
Journal:  Pulm Pharmacol Ther       Date:  2004       Impact factor: 3.410

7.  Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions.

Authors:  K Egashira; T Inou; Y Hirooka; A Yamada; Y Maruoka; H Kai; M Sugimachi; S Suzuki; A Takeshita
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

8.  Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.

Authors:  J A Panza; C E García; C M Kilcoyne; A A Quyyumi; R O Cannon
Journal:  Circulation       Date:  1995-03-15       Impact factor: 29.690

9.  Atherosclerosis and responses of human isolated coronary arteries to endothelium-dependent and -independent vasodilators.

Authors:  G Berkenboom; P Unger; J Fontaine
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

10.  Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1.

Authors:  B P Damiano; W M Cheung; R J Santulli; W P Fung-Leung; K Ngo; R D Ye; A L Darrow; C K Derian; L de Garavilla; P Andrade-Gordon
Journal:  J Pharmacol Exp Ther       Date:  1999-02       Impact factor: 4.030

View more
  11 in total

1.  Featured Article: Differential regulation of endothelial nitric oxide synthase phosphorylation by protease-activated receptors in adult human endothelial cells.

Authors:  Lakeisha C Tillery; Tenille A Epperson; Satoru Eguchi; Evangeline D Motley
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-04

2.  Preserved arterial vasodilatation via endothelial protease-activated receptor-2 in obese type 2 diabetic mice.

Authors:  Satomi Kagota; Elizabeth Chia; John J McGuire
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

3.  Protection of protease-activated receptor 2 mediated vasodilatation against angiotensin II-induced vascular dysfunction in mice.

Authors:  Elizabeth Chia; Satomi Kagota; Enoka P Wijekoon; John J McGuire
Journal:  BMC Pharmacol       Date:  2011-09-28

4.  Small caliber arterial endothelial cells calcium signals elicited by PAR2 are preserved from endothelial dysfunction.

Authors:  John C Hennessey; Bruno D Stuyvers; John J McGuire
Journal:  Pharmacol Res Perspect       Date:  2015-03

Review 5.  Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice.

Authors:  Kristy L Jackson; Geoffrey A Head; Cindy Gueguen; Emily R Stevenson; Kyungjoon Lim; Francine Z Marques
Journal:  Front Physiol       Date:  2019-10-18       Impact factor: 4.566

6.  Endothelial transcriptomics reveals activation of fibrosis-related pathways in hypertension.

Authors:  Jonathan W Nelson; Mohammed Z Ferdaus; James A McCormick; Jessica Minnier; Sanjiv Kaul; David H Ellison; Anthony P Barnes
Journal:  Physiol Genomics       Date:  2018-01-08       Impact factor: 3.107

7.  Genotypic analysis of the female BPH/5 mouse, a model of superimposed preeclampsia.

Authors:  Jenny L Sones; Christina C Yarborough; Valerie O'Besso; Alexander Lemenze; Nataki C Douglas
Journal:  PLoS One       Date:  2021-07-16       Impact factor: 3.240

8.  Attenuated vasodilator effectiveness of protease-activated receptor 2 agonist in heterozygous par2 knockout mice.

Authors:  John C Hennessey; John J McGuire
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

9.  Blood pressures, heart rate and locomotor activity during salt loading and angiotensin II infusion in protease-activated receptor 2 (PAR2) knockout mice.

Authors:  John J McGuire; Bruce N Van Vliet; Sarah J Halfyard
Journal:  BMC Physiol       Date:  2008-10-21

Review 10.  Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic Review.

Authors:  Satomi Kagota; Kana Maruyama; John J McGuire
Journal:  Biomed Res Int       Date:  2016-02-23       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.